首页> 外国专利> Orally extended-release pharmaceutical composition containing hydromorphone hydrochloride

Orally extended-release pharmaceutical composition containing hydromorphone hydrochloride

机译:含有盐酸氢吗啡酮的口服缓释药物组合物

摘要

A prolonged release pharmaceutical composition comprising (A) hydromorphone hydrochloride or oxycodone hydrochloride hydrate, (B) hydroxypropylmethylcellulose acetate succinate having a median statistic (D50) of 40 µm or less, (C) hydroxypropylcellulose and ( D) a saccharide, in which the content ratio of component (C) to component (B) by weight in the composition, (C) / (B), is 10/4 to 7/7.
机译:一种缓释药物组合物,其包含(A)氢吗啡酮盐酸盐或羟考酮盐酸盐水合物,(B)中值统计值(D50)为40μm以下的羟丙基甲基纤维素乙酸琥珀酸酯,(C)羟丙基纤维素和(D)糖,其中组合物中组分(C)与组分(B)的重量比(C)/(B)为10/4至7/7。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号